Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2017, Article ID 3981358, 7 pages
https://doi.org/10.1155/2017/3981358
Research Article

Preliminary 19F-MRS Study of Tumor Cell Proliferation with 3′-deoxy-3′-fluorothymidine and Its Metabolite (FLT-MP)

1Division of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
2Convergence Institute of Biomedical Engineering and Biomaterials, Seoul National University of Science & Technology, Seoul, Republic of Korea
3Division of Medical Radiation Equipment, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
4Department of Chemical & Biomolecular Engineering, Seoul National University of Science & Technology, Seoul, Republic of Korea
5Department of Nuclear Medicine, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea

Correspondence should be addressed to Jung Young Kim; rk.er.smarik@mikyj and Ji-Ae Park; rk.er.smarik@krapj

Received 11 May 2017; Accepted 17 July 2017; Published 26 September 2017

Academic Editor: Giancarlo Pascali

Copyright © 2017 In Ok Ko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Schwartz, Y. Tamura, R. Jordan, J. R. Grierson, and K. A. Krohn, “Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs,” Journal of Nuclear Medicine, vol. 44, pp. 2027–2032, 2003. View at Google Scholar · View at Scopus
  2. J. R. Bading and A. F. Shields, “Imaging of cell proliferation: status and prospects,” Journal of Nuclear Medicine, vol. 49, supplement 2, pp. 64S–80S, 2008. View at Publisher · View at Google Scholar
  3. V. W. Hu, G. E. Black, A. Torres-Duarte, and F. P. Abramson, “3H-thymidine is a defective tool with which to measure rates of DNA synthesis,” The FASEB journal: official publication of the Federation of American Societies for Experimental Biology, vol. 16, no. 11, pp. 1456-1457, 2002. View at Google Scholar · View at Scopus
  4. S. Nimmagadda and A. F. Shields, “The role of DNA synthesis imaging in cancer in the era of targeted therapeutics,” Cancer and Metastasis Reviews, vol. 27, no. 4, pp. 575–587, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. M. Kenny, E. O. Aboagye, and P. M. Price, “Positron emission tomography imaging of cell proliferation in oncology,” Clinical Oncology, vol. 16, no. 3, pp. 176–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Christman, E. J. Crawford, M. Friedkin, and A. P. Wolf, “Detection of DNA Synthesis in Intact Organisms with Positron-Emitting [Methyl-11C]Thymidine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 69, no. 4, pp. 988–992, 1972. View at Publisher · View at Google Scholar
  7. T. Tahara, Z. Zhang, M. Ohno et al., “A novel 11C-labeled thymidine analog, [11C]AZT, for tumor imaging by positron emission tomography,” EJNMMI Research, vol. 5, 124, no. 1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. D. A. Mankoff, A. F. Shields, J. M. Link et al., “Kinetic analysis of 2-[11C]thymidine PET imaging studies: Validation studies,” Journal of Nuclear Medicine, vol. 40, no. 4, pp. 614–624, 1999. View at Google Scholar · View at Scopus
  9. J. Toyohara, M. Okada, C. Toramatsu, K. Suzuki, and T. Irie, “Feasibility studies of 4′-[methyl-11C]thiothymidine as a tumor proliferation imaging agent in mice,” Nuclear Medicine and Biology, vol. 35, no. 1, pp. 67–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Mankoff, A. F. Shields, M. M. Graham, J. M. Link, J. F. Eary, and K. A. Krohn, “Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: Compartmental model and mathematical analysis,” Journal of Nuclear Medicine, vol. 39, no. 6, pp. 1043–1055, 1998. View at Google Scholar · View at Scopus
  11. A. F. Shields, “PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls,” The Journal of Nuclear Medicine, vol. 44, no. 9, pp. 1432–1434, 2003. View at Google Scholar · View at Scopus
  12. W. Chen, T. Cloughesy, N. Kamdar et al., “Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG,” Journal of Nuclear Medicine, vol. 46, no. 6, pp. 945–952, 2005. View at Google Scholar · View at Scopus
  13. A. F. Shields, J. R. Grierson, B. M. Dohmen et al., “Imaging proliferation in vivo with [F-18]FLT and positron emission tomography,” Nature Medicine, vol. 4, no. 11, pp. 1334–1336, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. E. T. McKinley, G. D. Ayers, R. A. Smith et al., “Limits of [18F]-FLT PET as a Biomarker of Proliferation in Oncology,” PLoS ONE, vol. 8, no. 3, Article ID e58938, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Li, M. Araya, M. Elliott et al., “Monitoring cellular accumulation of 3-deoxy-3-fluorothymidine (FLT) and its monophosphate metabolite (FLT-MP) by LC-MS/MS as a measure of cell proliferation in vitro,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 879, no. 28, pp. 2963–2970, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Ruiz-Cabello, B. P. Barnett, P. A. Bottomley, and J. W. M. Bulte, “Fluorine (19F) MRS and MRI in biomedicine,” NMR in Biomedicine, vol. 24, no. 2, pp. 114–129, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. R. B. van Heeswijk, Y. Pilloud, U. Flögel, J. Schwitter, and M. Stuber, “Fluorine-19 magnetic resonance angiography of the mouse,” PLoS ONE, vol. 7, no. 7, Article ID e42236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Tirotta, V. Dichiarante, C. Pigliacelli et al., “(19)F magnetic resonance imaging (MRI): from design of materials to clinical applications,” Chemical Reviews, vol. 115, no. 2, pp. 1106–1129, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Yue, Z. Wang, L. Zhu et al., “Novel 19F activatable probe for the detection of matrix metalloprotease-2 activity by MRI/MRS,” Molecular Pharmaceutics, vol. 11, no. 11, pp. 4208–4217, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Gonzales, H. A. I. Yoshihara, N. Dilek et al., “In-vivo detection and tracking of T cells in various organs in a melanoma tumor model by 19F-fluorine MRS/MRI,” PLoS ONE, vol. 11, no. 10, Article ID e0164557, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Yu, Y. Yang, S. Bo et al., “Design and Synthesis of Fluorinated Dendrimers for Sensitive 19F MRI,” Journal of Organic Chemistry, vol. 80, no. 9, pp. 4443–4449, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. K. A. Krohn, D. A. Mankoff, and J. F. Eary, “Imaging cellular proliferation as a measure of response to therapy,” Journal of Clinical Pharmacology, vol. 41, (suppl), pp. 96S–103S, 2001. View at Publisher · View at Google Scholar
  23. P. Caravan, “Strategies for increasing the sensitivity of gadolinium based MRI contrast agents,” Chemical Society Reviews, vol. 35, no. 6, pp. 512–523, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Negendank, “Studies of human tumors by MRS: A review,” NMR in Biomedicine, vol. 5, no. 5, pp. 303–324, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Albers, R. Bok, A. P. Chen et al., “Hyperpolarized 13C lactate, pyruvate, and alanine: Noninvasive biomarkers for prostate cancer detection and grading,” Cancer Research, vol. 68, no. 20, pp. 8607–8615, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. D. MacKenzie, Y.-F. Yen, D. Mayer, J. S. Tropp, R. E. Hurd, and D. M. Spielman, “Detection of inflammatory arthritis by using hyperpolarized 13C-pyruvate with MR imaging and spectroscopy,” Radiology, vol. 259, no. 2, pp. 414–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. K. R. Keshari and D. M. Wilson, “Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization,” Chemical Society Reviews, vol. 43, no. 5, pp. 1627–1659, 2014. View at Publisher · View at Google Scholar · View at Scopus